Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.
about
Immune Reconstitution after Allogeneic Hematopoietic Stem Cell TransplantationViraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trialImproving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantationCytomegalovirus infection- and age-dependent changes in human CD8+ T-cell cytokine expression patternsHumoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donorsDetection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma.Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccineEngineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infectionCytomegalovirus viral load and virus-specific immune reconstitution after peripheral blood stem cell versus bone marrow transplantationEvaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice.Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients.Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.The immune response to human CMVDonor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplantGraft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interactionCytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.Natural and adoptive T-cell immunity against herpes family viruses after allogeneic hematopoietic stem cell transplantation.Vaccine therapy for cytomegalovirus in the setting of allogeneic hematopoietic cell transplantation.The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation.Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.Broad spectrum antiviral T cells for viral complications after hematopoietic stem cell transplantation.Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation.Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation.Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry.Immune reconstitution to cytomegalovirus following partially matched-related donor transplantation: impact of in vivo T-cell depletion and granulocyte colony-stimulating factor-primed peripheral blood/bone marrow mixed grafts.Management of cytomegalovirus infection in haemopoietic stem cell transplantation.Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients.Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation.Appearance of cytomegalovirus-specific T-cells predicts fast resolution of viremia post hematopoietic stem cell transplantation.Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation.A Low Incidence of Cytomegalo Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation Despite a High SeroprevalenceLarge-Scale Screening of HCMV-Seropositive Blood Donors Indicates that HCMV Effectively Escapes from Antibodies by Cell-Associated Spread
P2860
Q28072627-6D38DF97-A67E-42B0-997A-338E57EF03CBQ33429827-7880CCBE-C57E-4165-970C-529E699EF1D5Q33597783-BEB2D6F6-880B-436E-9E70-576F799B23DBQ33909200-6953EACF-6039-401F-9D87-6A6379C1786BQ34162822-61CBDEEE-EF14-444F-B8FA-BEEBCD6BB700Q34616701-79FDA68F-8523-4537-8FDB-09A15F461332Q34788895-81DB637D-DD5C-4190-A840-2813FE165AAEQ35094029-03662E96-F898-4AF9-8AD3-BFE0FBD295CFQ35196400-B05AE87A-39D8-47F1-B4A2-1626821FFC91Q35613340-4DD5AEAF-7062-4622-9AF6-2B25A8033C9CQ35693349-B50AF6AE-4122-47BA-AED0-56E43D3EE6E6Q35842287-813D968B-FFB0-4A75-9F06-067F73D2B0A6Q35940701-2D6E3348-C201-4AB5-962C-D44031271886Q36374295-D926E67B-7A78-4D13-AEF1-BE103A42EA42Q36517022-1D852646-C3A9-4EAD-BB97-4A0A21CE20FDQ36862415-ABFB64B0-A5C2-4A31-ACB3-40A6C8E0DBAEQ37473909-29447F06-C4D0-4839-AF76-679DE2960CAEQ37559627-90ABE65E-F105-484C-8E3A-C79C0123EF90Q37888687-B320A83A-5533-4548-AFCE-340D82F2AB75Q38281851-2ED04FEF-6BAA-4CED-9178-6FD76B3DDD23Q38547042-4F9293B0-7515-4186-837C-A88AFF6C5D01Q38617612-17C3CDD9-FD73-49A4-85CE-C9A241D4BE29Q39018399-D29EB18B-DAB0-4AEB-948B-BE91E75064EBQ40370932-B0ABB51C-DBBF-4BDA-9AC0-95E666FE6268Q40497816-9CE81879-2AD4-4A03-9943-4362CDB79306Q40859295-FF248F88-85EB-4F28-A0A1-7AB1DA14B834Q41104283-95C8C5E3-3E1E-4194-92BE-A131C16DA6D5Q42182292-CF8FF28F-427C-4867-B9CA-AB75B0EE11DDQ42214333-87D52512-F2BE-4838-8E1E-12D008C71427Q42271011-CC3BF50D-E0F9-43D4-8C7D-2D8EE683E89BQ44700785-F303F910-76EB-4D9B-9A3D-AD86546DD24CQ44714539-6A7CEBDC-A57F-4E67-854F-0F3F650C6EF5Q44793485-942AF1A9-8ED7-4EBF-8021-F5966781D53EQ44946202-E8CD8CEB-86DC-404B-8CA4-6CB714397234Q47369032-0CEC5804-9F12-4D87-A048-9A0101D3F8D2Q48905387-C563D942-739C-4674-B54E-5CB8D64C24E6Q52564628-064E9BF0-58B9-4F10-B949-E2DB9091C4F7Q58125059-B3DB33AA-6684-42BF-8890-B0F29869E191Q58738833-4ADDE775-E0E5-449A-B8D0-8D24DD93F7A1
P2860
Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of donor CMV status on ...... ositive transplant recipients.
@en
Impact of donor CMV status on ...... ositive transplant recipients.
@nl
type
label
Impact of donor CMV status on ...... ositive transplant recipients.
@en
Impact of donor CMV status on ...... ositive transplant recipients.
@nl
prefLabel
Impact of donor CMV status on ...... ositive transplant recipients.
@en
Impact of donor CMV status on ...... ositive transplant recipients.
@nl
P2093
P2860
P1433
P1476
Impact of donor CMV status on ...... ositive transplant recipients.
@en
P2093
Don J Diamond
Ghislaine Gallez-Hawkins
John A Zaia
Joycelynne M Palmer
Ricardo Spielberger
Ryotaro Nakamura
Simon F Lacey
Stephen J Forman
Wendi Zhou
P2860
P304
P356
10.1182/BLOOD-2009-02-203307
P407
P577
2009-04-15T00:00:00Z